Rate Control in Patients With Atrial Fibrillation

• Status: Not yet recruiting
• Trial end date: 2022-06-30
• Target enrollment: 0
• Participant gender: All

Summary

To search for the best marker for the patients in atrial fibrillation with rate control

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Taiwan University Hospital
• Treatments: Atenolol; Bisoprolol; Digoxin; Diltiazem; Metoprolol; Nebivolol; Propranolol; Verapamil

Criteria

Inclusion Criteria:

1. 20~90 years old

2. Rate control is preferred after shared decision making

Exclusion Criteria:

1. cannot cooperate with or complete CPET

2. has contraindication for CPET, such as uncontrolled heart failure, hypertension, angina, valvular heart disease, lung function impariment that SaO2<90% at room air.

3. Ventricular rate below 80/min before any medication

4. Permanent pacemaker implanted